{"id":"NCT01899742","sponsor":"GlaxoSmithKline","briefTitle":"The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium","officialTitle":"DB2116960: A Randomized, Double-Dummy, Parallel Group, Multicenter Trial Comparing the Efficacy and Safety of UMEC/VI (a Fixed Combination of Umeclidinium and Vilanterol) With Tiotropium In Subjects With COPD Who Continue To Have Symptoms on Tiotropium","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-09-15","primaryCompletion":"2015-07-22","completion":"2015-07-22","firstPosted":"2013-07-15","resultsPosted":"2016-02-25","lastUpdate":"2018-01-24"},"enrollment":497,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"Umeclidinium/Vilanterol 62.5/25 mcg","otherNames":[]},{"type":"DRUG","name":"Tiotropium 18 mcg","otherNames":[]}],"arms":[{"label":"Umeclidinium/Vilanterol","type":"EXPERIMENTAL"},{"label":"Tiotropium","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective is to compare the efficacy of UMEC/VI Inhalation Powder (62.5/25 mcg) once-daily with tiotropium (18 mcg) once-daily over 12 weeks for the treatment of subjects with COPD who have received tiotropium and continue to have symptoms while on tiotropium.","primaryOutcome":{"measure":"Change From Baseline in Trough Forced Expiratory Volume in One Second (FEV1) on Day 85 (Visit 8)","timeFrame":"Baseline (BL) and Day 85","effectByArm":[{"arm":"Umeclidinium/Vilanterol 62.5/25 µg","deltaMin":0.074,"sd":0.0155},{"arm":"Tiotropium Bromide 18 µg","deltaMin":-0.014,"sd":0.0155}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":15,"exclusionCount":43},"locations":{"siteCount":64,"countries":["United States","Argentina","Estonia","Germany","Norway","Russia","South Africa","South Korea","Sweden","Ukraine"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":247},"commonTop":["Nasopharyngitis","Headache"]}}